ZA943047B - Human osteoclast-derived cathepsin - Google Patents
Human osteoclast-derived cathepsinInfo
- Publication number
- ZA943047B ZA943047B ZA943047A ZA943047A ZA943047B ZA 943047 B ZA943047 B ZA 943047B ZA 943047 A ZA943047 A ZA 943047A ZA 943047 A ZA943047 A ZA 943047A ZA 943047 B ZA943047 B ZA 943047B
- Authority
- ZA
- South Africa
- Prior art keywords
- human osteoclast
- derived cathepsin
- cathepsin
- derived
- osteoclast
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/208,007 US5501969A (en) | 1994-03-08 | 1994-03-08 | Human osteoclast-derived cathepsin |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA943047B true ZA943047B (en) | 1995-11-04 |
Family
ID=22772846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA943047A ZA943047B (en) | 1994-03-08 | 1994-05-03 | Human osteoclast-derived cathepsin |
Country Status (8)
Country | Link |
---|---|
US (10) | US5501969A (xx) |
EP (1) | EP0752844A4 (xx) |
JP (1) | JPH09510347A (xx) |
KR (1) | KR970701725A (xx) |
CN (1) | CN1150754A (xx) |
CA (3) | CA2380690C (xx) |
WO (1) | WO1995024182A1 (xx) |
ZA (1) | ZA943047B (xx) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US6403304B1 (en) * | 1993-04-06 | 2002-06-11 | Forsyth Dental Infirmary For Children | Human osteoclast-specific and -related DNA sequences |
JPH08510902A (ja) * | 1993-04-06 | 1996-11-19 | フォーシス デンタル インファーマリー フォー チルドレン | ヒト破骨細胞特異的およびヒト破骨細胞関連遺伝子 |
US5672509A (en) * | 1993-08-25 | 1997-09-30 | Pfizer Inc. | hPDE IV-C: a human phosphodiesterase IV isozyme |
US5501969A (en) * | 1994-03-08 | 1996-03-26 | Human Genome Sciences, Inc. | Human osteoclast-derived cathepsin |
US6544767B1 (en) | 1994-10-27 | 2003-04-08 | Axys Pharmaceuticals, Inc. | Cathespin O2 protease |
US5736357A (en) * | 1994-10-27 | 1998-04-07 | Arris Pharmaceutical | Cathespin O protease |
NZ324921A (en) * | 1995-10-30 | 2000-07-28 | Smithkline Beecham Corp | Cathepsin K crystal structure and methods of identifying inhibitors of this protease |
AP9801222A0 (en) * | 1995-10-30 | 1998-06-30 | Smithkline Beecham Corp | Proatease inhibitors. |
US6586466B2 (en) | 1995-10-30 | 2003-07-01 | Smithkline Beecham Corporation | Carbohydrazide-protease inhibitors |
ATE255126T1 (de) * | 1996-04-22 | 2003-12-15 | Massachusetts Inst Technology | Unterdrückung von immunantwort durch hemmung von cathepsin s |
US5976830A (en) * | 1996-05-24 | 1999-11-02 | The Ohio State University Research Foundation | Methods of producing doxorubicin |
AU6333296A (en) * | 1996-06-14 | 1998-01-07 | Human Genome Sciences, Inc. | Cathepsin k gene |
EP0812916A3 (en) * | 1996-06-14 | 1998-12-09 | Smithkline Beecham Corporation | Cathepsin k gene |
US5861298A (en) * | 1996-06-17 | 1999-01-19 | Smithkline Beecham Corporation | Cathepsin K gene |
AU3802297A (en) * | 1996-07-03 | 1998-01-21 | Novadx, Inc. | Method for detecting degenerative bone disease |
US5830850A (en) * | 1996-08-28 | 1998-11-03 | Mount Sinai School Of Medicine Of The City Of New York | Methods for the treatment of bone resorption disorders, including osteoporosis |
US5776759A (en) | 1996-09-26 | 1998-07-07 | Incyte Pharmaceuticals, Inc. | Two novel human cathepsin proteins |
US6420140B1 (en) * | 1996-10-11 | 2002-07-16 | Abgenix, Inc. | Production of multimeric protein by cell fusion method |
WO1998020024A1 (en) * | 1996-11-04 | 1998-05-14 | Merck Frosst Canada & Co. | Ligands for phosphatase binding assay |
CA2269659A1 (en) * | 1996-11-04 | 1998-05-14 | Merck Frosst Canada & Co. | Hydrolase binding assay |
WO1998019671A1 (en) * | 1996-11-07 | 1998-05-14 | The Mount Sinai School Of Medicine Of The City University Of New York | Methods and compositions for the treatment of bone resorption disorders, including osteoporosis |
US6348572B1 (en) | 1996-11-12 | 2002-02-19 | Merck Frosst Canada & Co. | Ligands for phosphatase binding assay |
GB9701888D0 (en) * | 1997-01-30 | 1997-03-19 | Ciba Geigy Ag | Novel methods |
US5948669A (en) * | 1997-02-26 | 1999-09-07 | Smithkline Beecham Corporation | Rat cathepsin K polynucleotide and polypeptide sequence |
JP2002537756A (ja) * | 1997-08-21 | 2002-11-05 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白 |
KR100631766B1 (ko) * | 1997-10-07 | 2006-10-09 | 오노 야꾸힝 고교 가부시키가이샤 | 폴리펩티드, 그 폴리펩티드를 암호화하는 cDNA 및그들의 용도 |
US20030044399A1 (en) * | 1998-12-23 | 2003-03-06 | Smithkline Beecham Corporation | Method of treatment |
US20030144175A1 (en) * | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
EP1232154A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
EP1229914A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
JP4787447B2 (ja) | 2000-01-20 | 2011-10-05 | メルク・シャープ・エンド・ドーム・コーポレイション | αvインテグリン受容体拮抗薬 |
AU4344101A (en) * | 2000-03-21 | 2001-10-03 | Smithkline Beecham Corp | Protease inhibitors |
US20040047853A1 (en) * | 2000-06-09 | 2004-03-11 | Dahl Soren W | Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
US6927056B2 (en) * | 2001-09-06 | 2005-08-09 | Incyte Corporation | Proteases |
AU2001292594A1 (en) * | 2000-09-08 | 2002-03-22 | Incyte Genomics, Inc. | Proteases |
EP1411933A1 (en) * | 2001-08-03 | 2004-04-28 | SmithKline Beecham Corporation | Alpha-ketoamide derivatives as cathepsin k inhibitors |
US20040038965A1 (en) * | 2001-10-09 | 2004-02-26 | Marquis, Jr. Robert W. | Protease inhibitors |
US7282512B2 (en) | 2002-01-17 | 2007-10-16 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors |
CA2478317A1 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate |
AU2003263738A1 (en) * | 2002-05-22 | 2003-12-02 | Smithkline Beecham Corporation | Protease inhibitors |
CA2532948A1 (en) * | 2003-07-21 | 2005-02-17 | Novartis Ag | Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
WO2005093421A1 (de) * | 2004-03-10 | 2005-10-06 | Biovendor Laboratory Medicine, Inc. | Enzymimmunoassay zur bestimmung von cathepsin k |
US7029902B2 (en) * | 2004-03-26 | 2006-04-18 | Applera Corporation | Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof |
UA87854C2 (xx) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена |
DE102005022047A1 (de) | 2005-05-09 | 2006-11-30 | Dade Behring Marburg Gmbh | Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung |
KR20080021634A (ko) * | 2005-06-02 | 2008-03-07 | 쉐링 코포레이션 | 약제학적 조성물 및 이를 사용한 치료 방법 |
AU2006252519B2 (en) | 2005-06-02 | 2012-08-30 | Merck Sharp & Dohme Corp. | HCV protease inhibitors in combination with food |
US20070237818A1 (en) * | 2005-06-02 | 2007-10-11 | Malcolm Bruce A | Controlled-release formulation of HCV protease inhibitor and methods using the same |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
GB0604187D0 (en) * | 2006-03-02 | 2006-04-12 | Fusion Antibodies Ltd | Peptide and uses thereof |
WO2007111866A2 (en) * | 2006-03-23 | 2007-10-04 | Schering Corporation | Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |
US7951367B2 (en) | 2006-11-15 | 2011-05-31 | The J. David Gladstone Institutes | Methods and compositions for reducing amyloid beta levels |
EP2105447A4 (en) * | 2006-12-20 | 2010-05-05 | Shino Test Corp | ANTIBODIES OF AVIAN ORIGIN CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB1, METHOD OF IMMUNOLOGICAL DETERMINATION FOR HUMAN HMGB1, AND IMMUNOLOGICAL DETERMINATION REAGENT FOR HUMAN HMGB1 |
KR20090007872A (ko) * | 2007-07-16 | 2009-01-21 | 인제대학교 산학협력단 | 자간전증 시에 특이적으로 발현되는 태반 단백질의스크리닝 방법 및 자간전증의 조기 진단 및 예측을 위한마커 |
KR101595238B1 (ko) | 2007-12-21 | 2016-02-18 | 리간드 파마슈티칼스 인코포레이티드 | 선택적 안드로겐 수용체 조절제(sarm) 및 이의 용도 |
US20090184034A1 (en) * | 2008-01-17 | 2009-07-23 | Kazuhiro Doi | Methods and systems for sorting bank notes, providing a change fund and balancing revenue |
WO2010005718A1 (en) * | 2008-06-16 | 2010-01-14 | University Of Louisville Research Foundation, Inc | Systems and methods for diagnosis and prognosis of cancer |
KR20110055687A (ko) * | 2008-09-25 | 2011-05-25 | 고쿠리츠 다이가쿠 호우징 도쿄 가이요우 다이가쿠 | 항참치 Vasa 항체 |
WO2010050554A1 (ja) * | 2008-10-31 | 2010-05-06 | 東レ株式会社 | ヒトcxcl1タンパク質の免疫学的測定方法 |
JP2012530253A (ja) * | 2009-06-16 | 2012-11-29 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | ペルオキシレドキシン4の診断的使用 |
CA2822351C (en) | 2010-12-21 | 2019-10-29 | The Lubrizol Corporation | Lubricating composition containing an antiwear agent |
TW201250246A (en) * | 2011-06-10 | 2012-12-16 | Univ Nat Yang Ming | Anti-NPC2 monoclonal antibodies and a method of detecting fatty liver tissue, cancer cells or cancer tissue by using them |
US8901144B2 (en) | 2013-02-07 | 2014-12-02 | Scifluor Life Sciences, Llc | Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives |
ES2763556T3 (es) | 2013-02-07 | 2020-05-29 | Scifluor Life Sciences Inc | Antagonistas fluorados de integrina |
JP6649902B2 (ja) | 2014-05-30 | 2020-02-19 | ファイザー・インク | 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体 |
TWI736529B (zh) | 2015-02-19 | 2021-08-21 | 美商賽氟洛生命科學公司 | 氟化之四氫啶基壬酸衍生物及其用途 |
CN111647584B (zh) * | 2020-05-14 | 2021-10-22 | 中国农业科学院农产品加工研究所 | 低温酸性蛋白酶PsAPA及其制备方法和应用 |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341012C (en) | 1982-09-27 | 2000-06-06 | Biogen, Inc. | Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
US4585553A (en) | 1982-11-24 | 1986-04-29 | Dai Nippon Insatsu Kabushiki Kaisha | Apparatus for the removal of solid particles from printing ink or other liquids |
US4538067A (en) | 1982-12-09 | 1985-08-27 | International Business Machines Corporation | Single grid focussed ion beam source |
FR2649891B1 (fr) | 1989-07-18 | 1991-10-25 | Centre Nat Rech Scient | Anticorps monoclonaux diriges contre les proenzymes de la cathepsine b-like et leurs applications biologiques |
DE4000221A1 (de) | 1990-01-05 | 1991-07-11 | Siemens Ag | Verfahren zur steuerung eines ueber ein proportionalventil verstellbaren stellgliedes |
EP0504938A3 (en) | 1991-03-22 | 1993-04-14 | Suntory Limited | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
JP3228347B2 (ja) | 1991-06-25 | 2001-11-12 | 三菱化学株式会社 | シクロプロペノン誘導体 |
JP3190431B2 (ja) | 1991-07-01 | 2001-07-23 | 三菱化学株式会社 | ケトン誘導体 |
US5223408A (en) | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
WO1993005795A1 (en) | 1991-09-13 | 1993-04-01 | Boron Biologicals, Inc. | Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
US5264801A (en) * | 1992-05-05 | 1993-11-23 | Picker International, Inc. | Active carbon barrier for x-ray tube targets |
US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
JPH08510902A (ja) | 1993-04-06 | 1996-11-19 | フォーシス デンタル インファーマリー フォー チルドレン | ヒト破骨細胞特異的およびヒト破骨細胞関連遺伝子 |
US6403304B1 (en) | 1993-04-06 | 2002-06-11 | Forsyth Dental Infirmary For Children | Human osteoclast-specific and -related DNA sequences |
US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
US5501969A (en) * | 1994-03-08 | 1996-03-26 | Human Genome Sciences, Inc. | Human osteoclast-derived cathepsin |
US6544767B1 (en) | 1994-10-27 | 2003-04-08 | Axys Pharmaceuticals, Inc. | Cathespin O2 protease |
US5736357A (en) | 1994-10-27 | 1998-04-07 | Arris Pharmaceutical | Cathespin O protease |
AUPN896596A0 (en) | 1996-03-27 | 1996-04-26 | Walter And Eliza Hall Institute Of Medical Research, The | Therapeutic molecules |
GB9611831D0 (en) | 1996-06-06 | 1996-08-07 | Agfa Gevaert Nv | A method for automatically detecting objects of a predefined size within an image |
AU6333296A (en) | 1996-06-14 | 1998-01-07 | Human Genome Sciences, Inc. | Cathepsin k gene |
AU3802297A (en) | 1996-07-03 | 1998-01-21 | Novadx, Inc. | Method for detecting degenerative bone disease |
US5830850A (en) | 1996-08-28 | 1998-11-03 | Mount Sinai School Of Medicine Of The City Of New York | Methods for the treatment of bone resorption disorders, including osteoporosis |
CA2269659A1 (en) | 1996-11-04 | 1998-05-14 | Merck Frosst Canada & Co. | Hydrolase binding assay |
WO1998020024A1 (en) | 1996-11-04 | 1998-05-14 | Merck Frosst Canada & Co. | Ligands for phosphatase binding assay |
GB9701888D0 (en) | 1997-01-30 | 1997-03-19 | Ciba Geigy Ag | Novel methods |
-
1994
- 1994-03-08 US US08/208,007 patent/US5501969A/en not_active Expired - Lifetime
- 1994-04-29 WO PCT/US1994/004781 patent/WO1995024182A1/en not_active Application Discontinuation
- 1994-04-29 JP JP7523420A patent/JPH09510347A/ja active Pending
- 1994-04-29 CA CA002380690A patent/CA2380690C/en not_active Expired - Fee Related
- 1994-04-29 CA CA002443236A patent/CA2443236A1/en not_active Abandoned
- 1994-04-29 CA CA002184908A patent/CA2184908C/en not_active Expired - Fee Related
- 1994-04-29 EP EP94914946A patent/EP0752844A4/en not_active Ceased
- 1994-04-29 CN CN94195094A patent/CN1150754A/zh active Pending
- 1994-05-03 ZA ZA943047A patent/ZA943047B/xx unknown
-
1995
- 1995-11-07 US US08/553,125 patent/US6475766B1/en not_active Expired - Fee Related
-
1996
- 1996-09-06 KR KR1019960704923A patent/KR970701725A/ko not_active Application Discontinuation
-
1997
- 1997-02-12 US US08/798,096 patent/US6387682B1/en not_active Expired - Fee Related
- 1997-02-12 US US08/798,095 patent/US6423507B1/en not_active Expired - Fee Related
- 1997-08-20 US US08/915,095 patent/US6383793B1/en not_active Expired - Fee Related
-
2001
- 2001-09-18 US US09/953,956 patent/US6475487B2/en not_active Expired - Fee Related
-
2002
- 2002-04-03 US US10/114,464 patent/US6680375B2/en not_active Expired - Fee Related
-
2003
- 2003-12-04 US US10/726,645 patent/US6994978B2/en not_active Expired - Fee Related
-
2005
- 2005-07-21 US US11/185,877 patent/US7235371B2/en not_active Expired - Fee Related
-
2007
- 2007-06-01 US US11/756,638 patent/US20080317754A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6475766B1 (en) | 2002-11-05 |
CA2184908A1 (en) | 1995-09-14 |
US6383793B1 (en) | 2002-05-07 |
US20060024299A1 (en) | 2006-02-02 |
US20080317754A1 (en) | 2008-12-25 |
CN1150754A (zh) | 1997-05-28 |
US6475487B2 (en) | 2002-11-05 |
US20020142448A1 (en) | 2002-10-03 |
US20050019889A1 (en) | 2005-01-27 |
US20020072107A1 (en) | 2002-06-13 |
US6423507B1 (en) | 2002-07-23 |
EP0752844A4 (en) | 1998-12-02 |
AU679990B2 (en) | 1997-07-17 |
KR970701725A (ko) | 1997-04-12 |
CA2380690A1 (en) | 1995-09-14 |
EP0752844A1 (en) | 1997-01-15 |
JPH09510347A (ja) | 1997-10-21 |
US7235371B2 (en) | 2007-06-26 |
CA2380690C (en) | 2003-12-30 |
US6994978B2 (en) | 2006-02-07 |
CA2443236A1 (en) | 1995-09-14 |
US5501969A (en) | 1996-03-26 |
WO1995024182A1 (en) | 1995-09-14 |
US6387682B1 (en) | 2002-05-14 |
CA2184908C (en) | 2002-07-02 |
AU6716194A (en) | 1995-09-25 |
US6680375B2 (en) | 2004-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA943047B (en) | Human osteoclast-derived cathepsin | |
EP0713672A3 (en) | endoscope | |
GB2317778B (en) | Endoscope | |
PL328822A1 (en) | Human bikinine | |
GB9411080D0 (en) | Treatment | |
ZA959616B (en) | Facial tissue carpack | |
EP0699419A3 (de) | Osteosynthetischer Fixateur | |
EP0774916A4 (en) | ENDOSCOPE | |
EP0847724A4 (en) | SPHYGMOMANOMETER | |
EP0793441A4 (en) | TONOMETER TO BE OPERATED BY THE PATIENT | |
GB9414157D0 (en) | Medical use | |
GB9410512D0 (en) | Novel treatment | |
AU124814S (en) | Massager | |
AU124815S (en) | Massager | |
EP0770087A4 (en) | HUMAN ELASTASE IV | |
HUP9901448A3 (en) | Novel medical use | |
GB9411635D0 (en) | Novel treatment | |
EP0797592A4 (en) | HUMAN STANNIOCALCIN ALPHA | |
ZA947865B (en) | Human glactokinase | |
GB9617550D0 (en) | Medical ice-pack | |
EP0795006A4 (en) | HUMAN MuT2 | |
EP0842187A4 (en) | HUMANCYSTANIN E | |
HUT72850A (en) | Human interleukin-6-inhibitor | |
ZA949714B (en) | Human MutT2 | |
GB9601042D0 (en) | Medical use |